retatrutide dosing phase 2 trial in adults with obesity over 104 weeks in the highest dose group had 30.3% weight loss. Nearly 2/3 reached BMI < 30 1 in 3 reached BMI < 25 Retatrutide Dosing Guide: 1-12 mg

Endocrinology 140 , 53565363 (1999)

Claims about GLP-1 support rely on marketing language, placebo effects, or unproven ingredients rather than rigorous human trials

We evaluated the enrollment rates to PRO data collection based on mode of initial outreach

Our chef-prepared, nutritionist-approved meals are specially crafted to complement your GLP-1 regimen, ensuring you get the right balance of nutrients while managing your weight

Amelia Cobo: conception and design of the work

Factors such as your baseline metabolic rate, genetic makeup, underlying insulin resistance, hormonal imbalances, and starting weight all influence how strongly and quickly you respond to GLP-1 medications